atopica logo

ATOPICA® (cyclosporine capsules) USP MODIFIED

Captar Logo

Capstar® (nitenpyram)

Clomicalm Logo 4C 2016

Clomicalm® (clomipramine hydrochloride)

Comfortis Logo

Comfortis® (spinosad)

Deramaxx logo

Deramaxx® (deracoxib)

Duramune Logp

Duramune®, Duramune Lyme® and LeptoVax®4

Galliprant Logo

Galliprant® (grapiprant tablets)

Interceptor® (milbemycin oxime)

Interceptor Plus Logo

Interceptor® Plus (milbemycin oxime/praziquantel)

Onsior logo

Onsior® Tablets for Dogs (robenacoxib)

onsior logo

Onsior® Injection (robenacoxib)

Osurnia® (florfenicol, terbinafine, betamethasone acetate)

PARASTAR Logo

Parastar® for Dogs

ParastarPLUS Logo

Parastar® Plus (fipronil/cyphenothrin)

Percorten-V Logo

Percorten®-V (desoxycorticosterone pivalate injectable suspension)

Placeholder until correct image

Rabvac®

Surolan Logo

Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate)

Trifexis logo

Trifexis® (spinosad + milbemycin oxime)

Ultra Duramune logo

ULTRA™ Duramune®

Vetspon logo

Vetspon

Zobuxa logo

Zobuxa® (enrofloxacin)

Duramune Logp
Duramune®, Duramune Lyme® and LeptoVax®4

Duramune Lyme

The only Lyme vaccines in combinations, offering solutions for any protocol

Real-world results and combinations that offer
lower volume and fewer needle sticks for less
pain and more comfort

img1

Trusted results you can rely on

  • 92.2% efficacy in a real world challenge study conducted in a highly endemic area1
  • 100% efficacy in a laboratory study2
  • Safe--even in Lyme-positive dogs3
  • Made with PureFilTM Technology, designed to reduce unwantd proteins and cellular debris

Duramune Lyme provides a broad antibody response to multiple Osps: OspA, OspB, OspC and many more4,5


Duramune-Lyme-Multiple-Osps-OL

Protection that Measures Up


11347-2 Chart 2-OL new

Lepto Vax 4

Innovative, tested and trusted

• The first 4-serovar vaccines to protect against emerging lepto serovars grippotyphosa and pomona
• Shown to be efficacious for spirochetemia against grippo and pomona by experimental challenge6
• In the largest-ever vaccine safety study7 — with 1.2 million dogs — Duramune products with Leptospira immunogens were no more likely to produce an adverse event than other vaccines, such as those for rabies
• Six standard 1 mL lepto vaccines and three ULTRATM Duramune 0.5 mL options

Unique Subunit4 Purification™ DESIGNED for enhanced safety and a COMFORTABLE injection

SubUnitGraphic

Choose ULTRATM Duramune Vaccines for Lepto Protection


This first and only 0.5 mL line available today. ULTRA vaccines were designed for a more comfortable injection with 50% less volume, but with the same protection that has made Duramune a trusted brand for more than 30 years.8

Millions of doses continue to provide outstanding results


With millions of doses administered, the effectiveness of these vaccines as a group is well-recognized. Vaccinating your patients regularly ensures frequent contact with dog owners and allows for updated risk assessment for changing threats.

Canine lepto vaccines from Elanco

Canine-lepto-vaccines-from-Elanco-OL new

Duramune and LeptoVax vaccines are made with PureFil™ Technology, designed to reduce unwanted proteins and cellular debris.

Always read, understand and follow the label and use directions.

References:


  1. Levy SA. Use of C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet Ther. 2002;3(4):420–424.

  2. Elanco Animal Health. Data on File.

  3. Levy, et al. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. JAVMA. 1993; 202(11):1834-1838

  4. Chu HJ, Chavez LG, Blumer BM, Sebring RW, Wasmoen, TL, Acree WM. Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. J Am Vet Med Assoc. 1992;201(3):403–411.

  5. Levy SA, Millership J, Glover S, Parker D, Hogan J, Heldorfer M, Ng T. Confirmation of Presence of Borrelia burgdorferi Outer Surface Protein C Antigen and Production of Antibodies to Borrelia burgdorferi Outer Surface Protein C in Dogs Vaccinated with a Whole-cell Borrelia burgdorferi Bacterin. The Journal of Applied Research in Veterinary Medicine. 2010 Jan 1;8(3):123.

  6. Elanco Animal Health. Data on file.

  7. Moore G, Guptil L, Ward M, et al. Adverse events diagnosed within three days of vaccine administration in dogs. JAVMA. 2005;227(7): 1102-1108.

  8. Elanco Animal Health. Data on File.


Duramune, Duramune Lyme, LeptoVax, ULTRA Duramune are trademarks of Elanco or its affiliates.